Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Favipiravir

A broad-spectrum antiviral that inhibits the RNA polymerase of RNA viruses, approved in Japan in 2014 against novel influenza strains and kept as a strategic stockpile in case of a pandemic. This family brings together the active ingredient and other impurities.

Did you know?It is a prodrug: inside the cell it becomes a fake nucleotide that the viral polymerase mistakes for guanosine or adenosine, jamming the copying of the viral genome.

FavipiravirGo to the active ingredient →
FavipiravirActive ingredientFavipiravirCat. No. P-F009-001CAS 259793-96-9

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.